ChatGPT and antimicrobial advice: the end of the consulting infection doctor?

  08 March 2023

Generative artificial intelligence (AI) models have proliferated in the past 2 years. ChatGPT—a large language model (LLM) developed by OpenAI (San Francisco, CA)—mimics natural language and solves cognitive problems by reinforcing learning from online resources using human feedback. Despite access to limited medical data, ChatGPT has medical licensing examination performance as an undergraduate third-year medical student, and has, therefore, stimulated urgent discussions within medicine. Stokel-Walker and van Noorden discuss the implications of generative AI for science and describe how ChatGPT “could answer some open-ended medical queries almost as well as the average human physician could, although it still had shortcomings and unreliabilities.

Author(s): Alex Howard, William Hope and Alessandro Gerada
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed